|
Mikhailova Z.D., Omarova Yu.V.
Kidney damage in patients with CHF and obesity (local register data)
|
№3 / 2022
|
|
Murkamilov I.T., Sabirov I.S., Murkamilova Zh.A., Fomin V.V., Sabirova A.I., Kudaybergenova I.O., Yusupov F.A., Maanaev T.I.
The prevalence of risk factors for cerebrovascular diseases in patients with chronic kidney disease and renal failure
|
№3 / 2022
|
|
I.T. Murkamilov, I.S. Sabirov, V.V. Fomin, Zh.A. Murkamilova
Evaluation of the possibilities of using calculation methods for estimating the glomerular filtration rate depending on the nosological type of socially significant diseases
|
№1 / 2019
|
|
I.T. Murkamilov, V.V. Fomin, K.A. Aytbayev, Z.R. Rayimzhanov, N.A. Redzhapova, F.A. Yusupov, Z.A. Aydarov
Chronic kidney disease and cerebrovascular disorders: the role of cystatin C
|
№3 / 2017
|
|
E.V. Bolotova, A.V. Dudnikova, V.V. Yavlyanskaya
Features of chronic kidney disease diagnosis in patients with chronic obstructive pulmonary disease
|
№1 / 2017
|
|
M.V. Kaplanyan, V.Yu. Ryasnyanskii, N.V. Vorokhobina
Using different equations for estimating glomerular filtration rate in patients with type 1 diabetes
|
№2 / 2016
|
|
A.P. Rebrov, A.L. Kuklina
Cystatin C and target organ damage in arterial hypertension
|
№2 / 2013
|
|
G.P. Aroutiunov, Oganesova L.G.
Frequently asked questions about glomerular filtration rate
|
№3 / 2009
|
Русский
